Sixty people worked at the plant. About five to eight are continuing there during the sale process.
“It is disappointing and it is a setback for us here because BioAmber was really an anchor flagship for the region, and if they aren’t successful in restructuring then we will lose that,” Marshall said.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.